Paravasthu Mukund, Chief Operating Officer of NovoCure Ltd ($NVCR), sold shares on the open market five times in the last year, totaling about $705 thousand. His most recent sale occurred on March 5, 2026. These transactions rank him 5,721st among 11,678 insiders by sale value, below the average of 8.6 million per insider and about six sales on average. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | A | Ordinary Shares | 45112 | $0.00 | 121,455.0000 | 111,981,981 | 59.09% | 0.04% |
| March 3, 2026 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | A | Stock Option (Right to Buy) | 58488 | $0.00 | 66,006.0000 | 111,981,981 | 777.97% | 0.05% |
| March 3, 2026 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | A | Stock Option (Right to Buy) | 7518 | $0.00 | 7,518.0000 | 111,981,981 | 9999.99% | 0.01% |
| March 5, 2026 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 43246 | $13.77 | 72,832.0000 | 111,981,981 | 37.26% | 0.04% |
| March 4, 2026 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 5377 | $13.31 | 116,078.0000 | 111,981,981 | 4.43% | 0.00% |
| Feb. 27, 2026 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 1555 | $13.66 | 76,751.0000 | 111,981,981 | 1.99% | 0.00% |
| March 2, 2026 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 408 | $13.49 | 76,343.0000 | 111,981,981 | 0.53% | 0.00% |
| Jan. 11, 2026 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | F | Ordinary Shares | 2133 | $14.35 | 78,306.0000 | 111,981,981 | 2.65% | 0.00% |
| Nov. 1, 2025 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | F | Ordinary Shares | 168 | $12.81 | 83,388.0000 | 111,981,981 | 0.20% | 0.00% |
| Nov. 4, 2025 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | F | Ordinary Shares | 2949 | $12.23 | 80,439.0000 | 111,981,981 | 3.54% | 0.00% |
| May 3, 2025 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 592 | $17.91 | 83,556.0000 | 109,915,429 | 0.70% | 0.00% |
| March 4, 2025 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | A | Ordinary Shares | 54975 | $18.19 | 84,148.0000 | 109,915,429 | 188.44% | 0.05% |
| March 4, 2025 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | A | Stock Options (Right to buy) | 81499 | $18.19 | 81,499.0000 | 109,915,429 | 9999.99% | 0.07% |
| March 3, 2025 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 250 | $18.54 | 29,173.0000 | 109,915,429 | 0.85% | 0.00% |
| Feb. 28, 2025 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 368 | $18.28 | 29,423.0000 | 109,915,429 | 1.24% | 0.00% |
| Feb. 27, 2025 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 1379 | $19.92 | 30,058.0000 | 109,915,429 | 4.39% | 0.00% |
| Feb. 27, 2025 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 267 | $20.55 | 29,791.0000 | 109,915,429 | 0.89% | 0.00% |
| Feb. 28, 2025 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 368 | $18.28 | 29,423.0000 | 109,915,429 | 1.24% | 0.00% |
| Feb. 27, 2025 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 1379 | $19.92 | 30,058.0000 | 109,915,429 | 4.39% | 0.00% |
| Feb. 27, 2025 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 267 | $20.55 | 29,791.0000 | 109,915,429 | 0.89% | 0.00% |
| Jan. 11, 2025 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 2160 | $26.81 | 31,437.0000 | 0 | 6.43% | 0.00% |
| Nov. 2, 2024 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 44 | $16.69 | 3,459.0000 | 0 | 1.26% | 0.00% |
| Nov. 4, 2024 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | A | Ordinary Shares | 30138 | $0.00 | 33,597.0000 | 0 | 871.29% | 0.00% |
| Nov. 4, 2024 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | A | Stock Option (Right to Buy) | 45620 | $16.59 | 45,620.0000 | 0 | 9999.99% | 0.00% |
| Nov. 1, 2024 | NovoCure Ltd | $NVCR | Paravasthu Mukund | Chief Operating Officer | S | Ordinary Shares | 160 | $15.88 | 3,503.0000 | 0 | 4.37% | 0.00% |